Literature DB >> 22592802

Development of experimental autoimmune encephalomyelitis (EAE) in mice requires vitamin D and the vitamin D receptor.

Yanping Wang1, Steven J Marling, Jinge G Zhu, Kyle S Severson, Hector F DeLuca.   

Abstract

The development of experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis, has been studied in mice that were (i) vitamin D-deficient, (ii) minus the vitamin D receptor, (iii) minus a vitamin D 25-hydroxylase, and (iv) minus the vitamin D 25-hydroxyvitamin D-1α-hydroxylase. EAE development was markedly suppressed in mice lacking the vitamin D receptor and partially suppressed in vitamin D-insufficient mice. However, the absence of either of the two key hydroxylases (i.e., 25-hydroxylase and 1α-hydroxylase) neither inhibits nor enhances the development of EAE. These results indicate that vitamin D and the vitamin D receptor are required for the development of EAE. The results also suggest that 1,25-dihydroxyvitamin D(3) may not play a role in this autoimmune response.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22592802      PMCID: PMC3365177          DOI: 10.1073/pnas.1206054109

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  Hypercalcemia produced by parathyroid hormone suppresses experimental autoimmune encephalomyelitis in female but not male mice.

Authors:  Terrence F Meehan; Janeen Vanhooke; Jean Prahl; Hector F Deluca
Journal:  Arch Biochem Biophys       Date:  2005-09-02       Impact factor: 4.013

2.  Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine.

Authors:  M F Holick; H K Schnoes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

3.  Biological activity of 25-hydroxyergocalciferol in rats.

Authors:  T Suda; H F DeLuca; Y Tanaka
Journal:  J Nutr       Date:  1970-09       Impact factor: 4.798

4.  Diet and the geographical distribution of multiple sclerosis.

Authors:  B W Agranoff; D Goldberg
Journal:  Lancet       Date:  1974-11-02       Impact factor: 79.321

5.  Dietary calcium is a major factor in 1,25-dihydroxycholecalciferol suppression of experimental autoimmune encephalomyelitis in mice.

Authors:  M T Cantorna; J Humpal-Winter; H F DeLuca
Journal:  J Nutr       Date:  1999-11       Impact factor: 4.798

Review 6.  Vitamin D, multiple sclerosis and inflammatory bowel disease.

Authors:  Margherita T Cantorna
Journal:  Arch Biochem Biophys       Date:  2011-11-10       Impact factor: 4.013

7.  1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.

Authors:  M T Cantorna; C E Hayes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  1,25-dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis.

Authors:  J M Lemire; D C Archer
Journal:  J Clin Invest       Date:  1991-03       Impact factor: 14.808

9.  Vitamin D deficiency suppresses cell-mediated immunity in vivo.

Authors:  S Yang; C Smith; J M Prahl; X Luo; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  1993-05-15       Impact factor: 4.013

10.  Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus.

Authors:  Julia B Zella; Laura C McCary; Hector F DeLuca
Journal:  Arch Biochem Biophys       Date:  2003-09-01       Impact factor: 4.013

View more
  20 in total

1.  Vitamin D deficiency: protective against enteric infection?

Authors:  Sylvia Christakos
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-11-01       Impact factor: 4.052

2.  Serum levels of 25-hydroxy vitamin D in normal Biozzi and C57BL/6 mice and during the course of chronic relapsing experimental autoimmune encephalomyelitis (CR EAE).

Authors:  Christopher Bolton; Janet Gates; Gavin Giovannoni
Journal:  Inflamm Res       Date:  2013-04-20       Impact factor: 4.575

Review 3.  Environmental Impact on Intestinal Stem Cell Functions in Mucosal Homeostasis and Tumorigenesis.

Authors:  Leonard H Augenlicht
Journal:  J Cell Biochem       Date:  2017-01-11       Impact factor: 4.429

4.  Vitamin D is a determinant of mouse intestinal Lgr5 stem cell functions.

Authors:  Karina Peregrina; Michele Houston; Cecilia Daroqui; Elena Dhima; Rani S Sellers; Leonard H Augenlicht
Journal:  Carcinogenesis       Date:  2014-10-24       Impact factor: 4.944

5.  Vitamin D Receptor Gene Polymorphism and the Risk of Multiple Sclerosis in South Eastern of Iran.

Authors:  Mehrnaz Narooie-Nejad; Maryam Moossavi; Adam Torkamanzehi; Ali Moghtaderi; Saeedeh Salimi
Journal:  J Mol Neurosci       Date:  2015-02-18       Impact factor: 3.444

6.  Calcium intervention ameliorates experimental model of multiple sclerosis.

Authors:  Dariush Haghmorad; Mohammad B Mahmoudi; Mahmoud Mahmoudi; Shahrzad Z T Rab; Maryam Rastin; Hamid Shegarfi; Gholamreza Azizi; Abbas Mirshafiey
Journal:  Oman Med J       Date:  2014-05

7.  Vitamin D3 receptor polymorphisms regulate T cells and T cell-dependent inflammatory diseases.

Authors:  Gonzalo Fernandez Lahore; Bruno Raposo; Marie Lagerquist; Claes Ohlsson; Pierre Sabatier; Bingze Xu; Mike Aoun; Jaime James; Xiaojie Cai; Roman A Zubarev; Kutty Selva Nandakumar; Rikard Holmdahl
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-21       Impact factor: 11.205

8.  Contribution of vitamin D insufficiency to the pathogenesis of multiple sclerosis.

Authors:  Charles Pierrot-Deseilligny; Jean-Claude Souberbielle
Journal:  Ther Adv Neurol Disord       Date:  2013-03       Impact factor: 6.570

Review 9.  Role of diet in regulating the gut microbiota and multiple sclerosis.

Authors:  John Michael S Sanchez; Ana Beatriz DePaula-Silva; Jane E Libbey; Robert S Fujinami
Journal:  Clin Immunol       Date:  2020-03-07       Impact factor: 3.969

Review 10.  Iranian consensus on use of vitamin D in patients with multiple sclerosis.

Authors:  Soodeh Razeghi Jahromi; Mohammad Ali Sahraian; Mansoureh Togha; Behnaz Sedighi; Vahid Shayegannejad; Alireza Nickseresht; Shahriar Nafissi; Niayesh Mohebbi; Nastran Majdinasab; Mohsen Foroughipour; Masoud Etemadifar; Nahid Beladi Moghadam; Hormoz Ayramlou; Fereshteh Ashtari; Shekoofe Alaie
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.